New York Life Trust’s Tenet Healthcare THC Stock Holding History

New York Life Trust’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-881	Closed	-$41K	–	225
2013 Q2	$41K	Buy	+881	New	+$39.4K	0.19%	151

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

New York Life Trust's THC Position: Q3 2013 in Review

New York Life Trust sold out of Tenet Healthcare (THC) in Q3 2013, closing a stake of 881 shares — an estimated $41K sold.

New York Life Trust first reported a position in THC in Q2 2013 and held it in 1 quarter. The position peaked at $41K in Q2 2013. 270 funds tracked by Wall St. Rank hold THC as of Q3 2013.

New York Life Trust reported no remaining Tenet Healthcare position as of Q3 2013 after selling out during the quarter.
New York Life Trust sold 881 Tenet Healthcare shares in Q3 2013, an estimated $41K.
New York Life Trust first reported a position in Tenet Healthcare in Q2 2013 and held it in 1 quarter.
New York Life Trust's Tenet Healthcare position peaked at $41K in Q2 2013.
270 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2013.

Based on New York Life Trust's 13F filing for Q3 2013, filed 14 Nov 2013.